Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The investigator believes simeprevir concentrations are unchanged when administered in combination with dolutegravir relative to administration alone. The investigator believes dolutegravir concentrations are unchanged when administered in combination with simeprevir. Additionally, the investigator believes simeprevir and dolutegravir are safe when administered alone and in combination.
Epistemonikos ID: 7c5a49cd87451e59990be93420941d78d7635af0
First added on: Mar 23, 2020